Seek Returns logo

ILMN vs. ZBH: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at ILMN and ZBH, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolILMNZBH
Company NameIllumina, Inc.Zimmer Biomet Holdings, Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryLife Sciences Tools & ServicesHealth Care Equipment & Supplies
Market Capitalization15.96 billion USD20.94 billion USD
ExchangeNasdaqGSNYSE
Listing DateJuly 28, 2000July 25, 2001
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of ILMN and ZBH by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

ILMN vs. ZBH: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolILMNZBH
5-Day Price Return0.71%3.52%
13-Week Price Return21.52%10.38%
26-Week Price Return-0.96%5.81%
52-Week Price Return-25.83%-5.42%
Month-to-Date Return-1.86%15.34%
Year-to-Date Return-24.57%0.08%
10-Day Avg. Volume1.39M1.86M
3-Month Avg. Volume2.15M2.13M
3-Month Volatility37.90%26.41%
Beta1.400.68

Profitability

Return on Equity (TTM)

ILMN

55.15%

Life Sciences Tools & Services Industry

Max
19.96%
Q3
11.55%
Median
6.22%
Q1
3.86%
Min
-6.95%

ILMN’s Return on Equity of 55.15% is exceptionally high, placing it well beyond the typical range for the Life Sciences Tools & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

ZBH

6.62%

Health Care Equipment & Supplies Industry

Max
34.53%
Q3
19.38%
Median
9.52%
Q1
4.86%
Min
-7.58%

ZBH’s Return on Equity of 6.62% is on par with the norm for the Health Care Equipment & Supplies industry, indicating its profitability relative to shareholder equity is typical for the sector.

ILMN vs. ZBH: A comparison of their Return on Equity (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Net Profit Margin (TTM)

ILMN

29.37%

Life Sciences Tools & Services Industry

Max
27.28%
Q3
16.17%
Median
7.24%
Q1
3.00%
Min
-3.05%

ILMN’s Net Profit Margin of 29.37% is exceptionally high, placing it well beyond the typical range for the Life Sciences Tools & Services industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

ZBH

10.51%

Health Care Equipment & Supplies Industry

Max
23.34%
Q3
13.06%
Median
9.53%
Q1
5.96%
Min
-3.87%

ZBH’s Net Profit Margin of 10.51% is aligned with the median group of its peers in the Health Care Equipment & Supplies industry. This indicates its ability to convert revenue into profit is typical for the sector.

ILMN vs. ZBH: A comparison of their Net Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Operating Profit Margin (TTM)

ILMN

30.21%

Life Sciences Tools & Services Industry

Max
33.15%
Q3
19.34%
Median
13.02%
Q1
8.05%
Min
-4.38%

An Operating Profit Margin of 30.21% places ILMN in the upper quartile for the Life Sciences Tools & Services industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

ZBH

16.09%

Health Care Equipment & Supplies Industry

Max
29.44%
Q3
17.80%
Median
13.95%
Q1
8.73%
Min
-3.56%

ZBH’s Operating Profit Margin of 16.09% is around the midpoint for the Health Care Equipment & Supplies industry, indicating that its efficiency in managing core business operations is typical for the sector.

ILMN vs. ZBH: A comparison of their Operating Profit Margin (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Profitability at a Glance

SymbolILMNZBH
Return on Equity (TTM)55.15%6.62%
Return on Assets (TTM)20.47%3.74%
Net Profit Margin (TTM)29.37%10.51%
Operating Profit Margin (TTM)30.21%16.09%
Gross Profit Margin (TTM)66.55%71.06%

Financial Strength

Current Ratio (MRQ)

ILMN

1.81

Life Sciences Tools & Services Industry

Max
4.76
Q3
2.77
Median
1.85
Q1
1.40
Min
0.43

ILMN’s Current Ratio of 1.81 aligns with the median group of the Life Sciences Tools & Services industry, indicating that its short-term liquidity is in line with its sector peers.

ZBH

1.87

Health Care Equipment & Supplies Industry

Max
4.90
Q3
3.05
Median
2.14
Q1
1.49
Min
0.86

ZBH’s Current Ratio of 1.87 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.

ILMN vs. ZBH: A comparison of their Current Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Debt-to-Equity Ratio (MRQ)

ILMN

0.88

Life Sciences Tools & Services Industry

Max
1.75
Q3
0.83
Median
0.41
Q1
0.18
Min
0.00

ILMN’s leverage is in the upper quartile of the Life Sciences Tools & Services industry, with a Debt-to-Equity Ratio of 0.88. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

ZBH

0.60

Health Care Equipment & Supplies Industry

Max
1.49
Q3
0.71
Median
0.45
Q1
0.14
Min
0.00

ZBH’s Debt-to-Equity Ratio of 0.60 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

ILMN vs. ZBH: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Interest Coverage Ratio (TTM)

ILMN

-2.28

Life Sciences Tools & Services Industry

Max
29.61
Q3
23.24
Median
6.07
Q1
2.18
Min
-14.08

ILMN has a negative Interest Coverage Ratio of -2.28. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.

ZBH

5.76

Health Care Equipment & Supplies Industry

Max
58.29
Q3
25.56
Median
9.06
Q1
3.60
Min
-28.92

ZBH’s Interest Coverage Ratio of 5.76 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.

ILMN vs. ZBH: A comparison of their Interest Coverage Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Financial Strength at a Glance

SymbolILMNZBH
Current Ratio (MRQ)1.811.87
Quick Ratio (MRQ)1.280.80
Debt-to-Equity Ratio (MRQ)0.880.60
Interest Coverage Ratio (TTM)-2.285.76

Growth

Revenue Growth

ILMN vs. ZBH: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

ILMN vs. ZBH: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

ILMN

0.00%

Life Sciences Tools & Services Industry

Max
1.80%
Q3
0.78%
Median
0.37%
Q1
0.00%
Min
0.00%

ILMN currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ZBH

1.02%

Health Care Equipment & Supplies Industry

Max
4.05%
Q3
1.76%
Median
0.71%
Q1
0.00%
Min
0.00%

ZBH’s Dividend Yield of 1.02% is consistent with its peers in the Health Care Equipment & Supplies industry, providing a dividend return that is standard for its sector.

ILMN vs. ZBH: A comparison of their Dividend Yield (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend Payout Ratio (TTM)

ILMN

0.00%

Life Sciences Tools & Services Industry

Max
156.00%
Q3
65.73%
Median
23.81%
Q1
0.00%
Min
0.00%

ILMN has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ZBH

23.39%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
72.47%
Median
27.49%
Q1
0.00%
Min
0.00%

ZBH’s Dividend Payout Ratio of 23.39% is within the typical range for the Health Care Equipment & Supplies industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

ILMN vs. ZBH: A comparison of their Dividend Payout Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Dividend at a Glance

SymbolILMNZBH
Dividend Yield (TTM)0.00%1.02%
Dividend Payout Ratio (TTM)0.00%23.39%

Valuation

Price-to-Earnings Ratio (TTM)

ILMN

12.31

Life Sciences Tools & Services Industry

Max
117.96
Q3
65.59
Median
37.26
Q1
27.51
Min
1.73

In the lower quartile for the Life Sciences Tools & Services industry, ILMN’s P/E Ratio of 12.31 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

ZBH

22.82

Health Care Equipment & Supplies Industry

Max
73.48
Q3
51.69
Median
34.31
Q1
25.74
Min
11.47

In the lower quartile for the Health Care Equipment & Supplies industry, ZBH’s P/E Ratio of 22.82 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

ILMN vs. ZBH: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Sales Ratio (TTM)

ILMN

3.61

Life Sciences Tools & Services Industry

Max
12.46
Q3
6.70
Median
4.24
Q1
2.68
Min
0.73

ILMN’s P/S Ratio of 3.61 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

ZBH

2.40

Health Care Equipment & Supplies Industry

Max
9.53
Q3
5.26
Median
3.39
Q1
2.13
Min
0.00

ZBH’s P/S Ratio of 2.40 aligns with the market consensus for the Health Care Equipment & Supplies industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

ILMN vs. ZBH: A comparison of their Price-to-Sales Ratio (TTM) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Price-to-Book Ratio (MRQ)

ILMN

6.69

Life Sciences Tools & Services Industry

Max
7.99
Q3
4.69
Median
3.30
Q1
1.88
Min
1.02

ILMN’s P/B Ratio of 6.69 is in the upper tier for the Life Sciences Tools & Services industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.

ZBH

1.44

Health Care Equipment & Supplies Industry

Max
10.85
Q3
5.98
Median
3.48
Q1
2.43
Min
0.69

ZBH’s P/B Ratio of 1.44 is in the lower quartile for the Health Care Equipment & Supplies industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

ILMN vs. ZBH: A comparison of their Price-to-Book Ratio (MRQ) against their respective Life Sciences Tools & Services and Health Care Equipment & Supplies industry benchmarks.

Valuation at a Glance

SymbolILMNZBH
Price-to-Earnings Ratio (TTM)12.3122.82
Price-to-Sales Ratio (TTM)3.612.40
Price-to-Book Ratio (MRQ)6.691.44
Price-to-Free Cash Flow Ratio (TTM)15.0215.78